Search

Displaying results 6181 - 6190 of 6279 in total
  1. Drug

    Aspoxicillin

    go.drugbank.com/drugs/DB13816
    Experimental

    Categories: Penicillin G
  2. Drug

    Hispidulin

    go.drugbank.com/drugs/DB14008
    Experimental

    Hispidulin (4',5,7-trihydroxy-6-methoxyflavone) is a potent benzodiazepine (BZD) receptor ligand with positive allosteric properties [A32513].

    Synonyms: Scutellarein 6-methyl ether, 4',5,7-Trihydroxy-6-methoxyflavone
  3. Drug

    Viper antivenom

    go.drugbank.com/drugs/DB14114
    ApprovedInvestigational

    Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies against snake venoms. ANAVIP, an equine-derived antivenom made with venom from Bothrops asper and Crotalus durissus, was first app...

  4. Drug

    MLN8054

    go.drugbank.com/drugs/DB13061
    Investigational

    MLN8054 has been used in trials studying the treatment of Colon Neoplasm, Breast Neoplasm, Bladder Neoplasm, Pancreatic Neoplasm, and Advanced Malignancies.

  5. Drug

    Troxerutin

    go.drugbank.com/drugs/DB13124
    Investigational

    Troxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.

    Mixtures: LACORYL® -T GEL, LACORYL® -T GELProducts: TROXEL %2 JEL, 40 G, Daflogel %2 Jel, 40 G
  6. Drug

    Nebacumab

    go.drugbank.com/drugs/DB13535
    Experimental

    Categories: Immunoglobulin M
  7. Drug

    Sulbenicillin

    go.drugbank.com/drugs/DB13693
    Investigational

    Categories: Penicillin G
  8. Drug

    Daporinad

    go.drugbank.com/drugs/DB12731
    Investigational

    Daporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.

  9. Drug

    Radium Ra-223

    go.drugbank.com/drugs/DB12813
    Investigational

    Radium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC).

  10. Drug

    Mesmulogene ancovacivec

    go.drugbank.com/drugs/DB06584
    Investigational

    Vaccination with MVA-MUC1-IL2 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing MUC1, a tumor associated antigen,